Ralph Graeser

2.7k total citations
50 papers, 2.0k citations indexed

About

Ralph Graeser is a scholar working on Molecular Biology, Oncology and Biomaterials. According to data from OpenAlex, Ralph Graeser has authored 50 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 19 papers in Oncology and 16 papers in Biomaterials. Recurrent topics in Ralph Graeser's work include Nanoparticle-Based Drug Delivery (15 papers), RNA Interference and Gene Delivery (6 papers) and Cancer Research and Treatments (6 papers). Ralph Graeser is often cited by papers focused on Nanoparticle-Based Drug Delivery (15 papers), RNA Interference and Gene Delivery (6 papers) and Cancer Research and Treatments (6 papers). Ralph Graeser collaborates with scholars based in Germany, United States and Switzerland. Ralph Graeser's co-authors include Felix Kratz, Barbara Kappes, Rainer Haag, Richard M. Franklin, Catarina Brito, Ronald De Hoogt, N. Esser, Clemens Unger, Suzana Vidic and John A. Hickman and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Cell Biology and PLoS ONE.

In The Last Decade

Ralph Graeser

49 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ralph Graeser Germany	28	962	551	426	404	275	50	2.0k
Yohei Mukai Japan	32	1.6k 1.6×	416 0.8×	352 0.8×	398 1.0×	73 0.3×	102	3.0k
Sharon A. Johnstone Canada	15	993 1.0×	251 0.5×	450 1.1×	850 2.1×	68 0.2×	20	1.7k
Troy O. Harasym Canada	21	1.3k 1.4×	306 0.6×	483 1.1×	915 2.3×	142 0.5×	45	2.2k
Wenxue Ma United States	26	1.1k 1.1×	624 1.1×	352 0.8×	453 1.1×	159 0.6×	84	2.5k
Ángel M. Carcaboso Spain	33	1.4k 1.5×	645 1.2×	305 0.7×	332 0.8×	71 0.3×	100	3.1k
Jianxin Dai China	26	964 1.0×	419 0.8×	286 0.7×	356 0.9×	147 0.5×	66	2.0k
Rudolph L. Juliano United States	30	2.4k 2.5×	197 0.4×	191 0.4×	243 0.6×	43 0.2×	56	2.9k
Tracy R. Daniels‐Wells United States	26	1.5k 1.6×	553 1.0×	454 1.1×	644 1.6×	34 0.1×	51	3.0k
Lei Yu China	32	1.1k 1.2×	982 1.8×	663 1.6×	495 1.2×	53 0.2×	104	2.7k
Frank Czubayko Germany	34	2.9k 3.0×	493 0.9×	385 0.9×	474 1.2×	42 0.2×	53	4.1k

Countries citing papers authored by Ralph Graeser

Since Specialization

Citations

This map shows the geographic impact of Ralph Graeser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph Graeser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph Graeser more than expected).

Fields of papers citing papers by Ralph Graeser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralph Graeser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph Graeser. The network helps show where Ralph Graeser may publish in the future.

Co-authorship network of co-authors of Ralph Graeser

This figure shows the co-authorship network connecting the top 25 collaborators of Ralph Graeser. A scholar is included among the top collaborators of Ralph Graeser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralph Graeser. Ralph Graeser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vidic, Suzana, Marta F Estrada, Kjersti Gjerde, et al.. (2018). PREDECT Protocols for Complex 2D/3D Cultures. Methods in molecular biology. 1888. 1–20. 3 indexed citations

Johnson, Melissa L., Manish R. Patel, Susanna V. Ulahannan, et al.. (2018). Phase I study of BI 754111 (anti-LAG-3) plus BI 754091(anti-PD-1) in patients (pts) with advanced solid cancers, followed by expansion in pts with microsatellite stable metastatic colorectal cancer (mCRC), anti-PD-(L)1-pretreated non-small cell lung cancer (NSCLC) and other solid tumors. Annals of Oncology. 29. viii441–viii441. 4 indexed citations

Mross, K., Heike Richly, Annette Frost, et al.. (2016). A phase I study of BI 811283, an Aurora B kinase inhibitor, in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 78(2). 405–417. 14 indexed citations

Ajaj, Khalid Abu, Ralph Graeser, & Felix Kratz. (2012). Zosuquidar and an albumin-binding prodrug of zosuquidar reverse multidrug resistance in breast cancer cells of doxorubicin and an albumin-binding prodrug of doxorubicin. Breast Cancer Research and Treatment. 134(1). 117–129. 21 indexed citations

Jantscheff, Peter, Martin Schlesinger, Lenka A. Taylor, et al.. (2011). Lysophosphatidylcholine Pretreatment Reduces VLA-4 and P-Selectin–Mediated B16.F10 Melanoma Cell Adhesion In vitro and Inhibits Metastasis-Like Lung Invasion In vivo. Molecular Cancer Therapeutics. 10(1). 186–197. 44 indexed citations

Kratz, Felix, Iduna Fichtner, & Ralph Graeser. (2011). Combination therapy with the albumin-binding prodrug of doxorubicin (INNO-206) and doxorubicin achieves complete remissions and improves tolerability in an ovarian A2780 xenograft model. Investigational New Drugs. 30(4). 1743–1749. 19 indexed citations

Goettert, Márcia Inês, et al.. (2011). A direct ELISA assay for quantitative determination of the inhibitory potency of small molecules inhibitors for JNK3. Journal of Pharmaceutical and Biomedical Analysis. 55(1). 236–240. 19 indexed citations

Héroult, Mélanie, Florence Schaffner, Dennis Pfaff, et al.. (2010). EphB4 Promotes Site-Specific Metastatic Tumor Cell Dissemination by Interacting with Endothelial Cell–Expressed EphrinB2. Molecular Cancer Research. 8(10). 1297–1309. 36 indexed citations

Elsadek, Bakheet, Ralph Graeser, N. Esser, et al.. (2010). Development of a novel prodrug of paclitaxel that is cleaved by prostate-specific antigen: An in vitro and in vivo evaluation study. European Journal of Cancer. 46(18). 3434–3444. 39 indexed citations

10.

Elsadek, Bakheet, Ralph Graeser, N. Esser, et al.. (2010). In vivo evaluation of a novel albumin-binding prodrug of doxorubicin in an orthotopic mouse model of prostate cancer (LNCaP). Prostate Cancer and Prostatic Diseases. 14(1). 14–21. 13 indexed citations

11.

Calderón, Marcelo, Pia Welker, Kai Licha, et al.. (2010). Development of efficient macromolecular prodrugs derived from dendritic polyglycerol. Journal of Controlled Release. 148(1). e24–e25. 15 indexed citations

12.

Tsurumi, Chizuko, N. Esser, Elke Firat, et al.. (2010). Non-Invasive In Vivo Imaging of Tumor-Associated CD133/Prominin. PLoS ONE. 5(12). e15605–e15605. 33 indexed citations

13.

Goettert, Márcia Inês, Ralph Graeser, & Stefan Laufer. (2010). Optimization of a nonradioactive immunosorbent assay for p38α mitogen-activated protein kinase activity. Analytical Biochemistry. 406(2). 233–234. 34 indexed citations

14.

Ajaj, Khalid Abu, Ralph Graeser, Iduna Fichtner, & Felix Kratz. (2009). In vitro and in vivo study of an albumin-binding prodrug of doxorubicin that is cleaved by cathepsin B. Cancer Chemotherapy and Pharmacology. 64(2). 413–418. 46 indexed citations

15.

Graeser, Ralph, et al.. (2009). INNO-206, the (6-maleimidocaproyl hydrazone derivative of doxorubicin), shows superior antitumor efficacy compared to doxorubicin in different tumor xenograft models and in an orthotopic pancreas carcinoma model. Investigational New Drugs. 28(1). 14–19. 63 indexed citations

16.

Xu, Shangjie, Ying Luo, Ralph Graeser, et al.. (2008). Development of pH-responsive core–shell nanocarriers for delivery of therapeutic and diagnostic agents. Bioorganic & Medicinal Chemistry Letters. 19(3). 1030–1034. 65 indexed citations

17.

Kappes, Barbara, Christian Doerig, & Ralph Graeser. (1999). An Overview of Plasmodium Protein Kinases. Parasitology Today. 15(11). 449–454. 49 indexed citations

18.

Färber, Petra M., Ralph Graeser, Richard M. Franklin, & Barbara Kappes. (1997). Molecular cloning and characterization of a second calcium-dependent protein kinase of Plasmodium falciparum1Note: Nucleotide sequence data reported in this paper are available in the EMBL, GenBank™ and DDJB databases under the accession number X99763.1. Molecular and Biochemical Parasitology. 87(2). 211–216. 33 indexed citations

19.

Graeser, Ralph, et al.. (1996). Plasmodium falciparum protein kinase 5 and the malarial nuclear division cycles. Molecular and Biochemical Parasitology. 82(1). 37–49. 67 indexed citations

20.

Ross‐Macdonald, Petra, Ralph Graeser, Barbara Kappes, Richard A. Franklin, & Donald H. Williamson. (1994). Isolation and expression of a gene specifying a cdc2‐like protein kinase from the human malaria parasite Plasmodium falciparum. European Journal of Biochemistry. 220(3). 693–701. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact